Sunshine Biopharma (SBFM) Invested Capital (2018 - 2019)

Sunshine Biopharma (SBFM) posted Invested Capital of $27541.0 for Q3 2019, down 1.18% on a QoQ basis from $27869.0 in Q2 2019.

Sunshine Biopharma (SBFM) Invested Capital (2018 - 2019) Analysis & Trends

Sunshine Biopharma's Invested Capital history runs 2 years deep, the most recent figure standing at $27541.0 for Q3 2019.

Quarterly Invested Capital changed N/A year-over-year to $27541.0 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was $27541.0 (down 74.57% YoY) and the FY2018 annual result came in at $20871.0, changed N/A from the prior year.
Invested Capital was $27541.0 for Q3 2019 at Sunshine Biopharma, down from $27869.0 in the prior quarter.
Across five years, Invested Capital topped out at $59558.0 in Q1 2019 and bottomed at $20871.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Haleon	92.29 Bn	90.43 Bn	-	1.11 Bn
2	Teva Pharmaceutical Industries	35.86 Bn	32.12 Bn	1.97 Bn	2.61 Bn
3	Zoetis	33.09 Bn	31.15 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	27.76 Bn	23.70 Bn	4.39 Bn	31.13 Bn
5	United Therapeutics	22.94 Bn	20.79 Bn	648.10 Mn	-
6	RedHill Biopharma	21.80 Bn	21.80 Bn	-	14.77 Mn
7	Viatris	20.51 Bn	18.70 Bn	1.16 Bn	1.93 Bn
8	Neurocrine Biosciences	18.16 Bn	16.84 Bn	800.70 Mn	-
9	Elanco Animal Health	12.84 Bn	12.41 Bn	785.00 Mn	73.00 Mn
10	Sunshine Biopharma	696,643.46	-6.22 Mn	2.18 Mn	-

Download Data